182 related articles for article (PubMed ID: 26198053)
1. Role of saposin C and D in auditory and vestibular function.
Lustig LR; Alemi S; Sun Y; Grabowski G; Akil O
Laryngoscope; 2016 Feb; 126(2):452-9. PubMed ID: 26198053
[TBL] [Abstract][Full Text] [Related]
2. Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking.
Sun Y; Witte DP; Zamzow M; Ran H; Quinn B; Matsuda J; Grabowski GA
Hum Mol Genet; 2007 Apr; 16(8):957-71. PubMed ID: 17353235
[TBL] [Abstract][Full Text] [Related]
3. Spiral ganglion degeneration and hearing loss as a consequence of satellite cell death in saposin B-deficient mice.
Akil O; Sun Y; Vijayakumar S; Zhang W; Ku T; Lee CK; Jones S; Grabowski GA; Lustig LR
J Neurosci; 2015 Feb; 35(7):3263-75. PubMed ID: 25698761
[TBL] [Abstract][Full Text] [Related]
4. Severe vestibular dysfunction and altered vestibular innervation in mice lacking prosaposin.
Akil O; Lustig LR
Neurosci Res; 2012 Apr; 72(4):296-305. PubMed ID: 22326583
[TBL] [Abstract][Full Text] [Related]
5. A mutation in the saposin C domain of the sphingolipid activator protein (Prosaposin) gene causes neurodegenerative disease in mice.
Yoneshige A; Suzuki K; Suzuki K; Matsuda J
J Neurosci Res; 2010 Aug; 88(10):2118-34. PubMed ID: 20175216
[TBL] [Abstract][Full Text] [Related]
6. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse.
Matsuda J; Kido M; Tadano-Aritomi K; Ishizuka I; Tominaga K; Toida K; Takeda E; Suzuki K; Kuroda Y
Hum Mol Genet; 2004 Nov; 13(21):2709-23. PubMed ID: 15345707
[TBL] [Abstract][Full Text] [Related]
7. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse.
Matsuda J; Vanier MT; Saito Y; Tohyama J; Suzuki K; Suzuki K
Hum Mol Genet; 2001 May; 10(11):1191-9. PubMed ID: 11371512
[TBL] [Abstract][Full Text] [Related]
8. Hearing and vestibular deficits in the Coch(-/-) null mouse model: comparison to the Coch(G88E/G88E) mouse and to DFNA9 hearing and balance disorder.
Jones SM; Robertson NG; Given S; Giersch AB; Liberman MC; Morton CC
Hear Res; 2011 Feb; 272(1-2):42-8. PubMed ID: 21073934
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
[TBL] [Abstract][Full Text] [Related]
10. The role of saposin C in Gaucher disease.
Tamargo RJ; Velayati A; Goldin E; Sidransky E
Mol Genet Metab; 2012 Jul; 106(3):257-63. PubMed ID: 22652185
[TBL] [Abstract][Full Text] [Related]
11. Progressive deafness and altered cochlear innervation in knock-out mice lacking prosaposin.
Akil O; Chang J; Hiel H; Kong JH; Yi E; Glowatzki E; Lustig LR
J Neurosci; 2006 Dec; 26(50):13076-88. PubMed ID: 17167097
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice.
Sun Y; Zamzow M; Ran H; Zhang W; Quinn B; Barnes S; Witte DP; Setchell KD; Williams MT; Vorhees CV; Grabowski GA
Hum Mol Genet; 2013 Jun; 22(12):2435-50. PubMed ID: 23446636
[TBL] [Abstract][Full Text] [Related]
13. Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse.
Sun Y; Ran H; Zamzow M; Kitatani K; Skelton MR; Williams MT; Vorhees CV; Witte DP; Hannun YA; Grabowski GA
Hum Mol Genet; 2010 Feb; 19(4):634-47. PubMed ID: 20015957
[TBL] [Abstract][Full Text] [Related]
14. A null mutation of mouse Kcna10 causes significant vestibular and mild hearing dysfunction.
Lee SI; Conrad T; Jones SM; Lagziel A; Starost MF; Belyantseva IA; Friedman TB; Morell RJ
Hear Res; 2013 Jun; 300():1-9. PubMed ID: 23528307
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo localization of the mouse saposin C activation region for acid beta-glucosidase.
Qi X; Kondoh K; Yin H; Wang M; Ponce E; Sun Y; Grabowski GA
Mol Genet Metab; 2002 Jul; 76(3):189-200. PubMed ID: 12126932
[TBL] [Abstract][Full Text] [Related]
16. A saposin deficiency model in Drosophila: Lysosomal storage, progressive neurodegeneration and sensory physiological decline.
Hindle SJ; Hebbar S; Schwudke D; Elliott CJH; Sweeney ST
Neurobiol Dis; 2017 Feb; 98():77-87. PubMed ID: 27913291
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of the mouse prosaposin (SGP-1) gene reveals the presence of an exon that is alternatively spliced in transcribed mRNAs.
Zhao Q; Hay N; Morales CR
Mol Reprod Dev; 1997 Sep; 48(1):1-8. PubMed ID: 9266755
[TBL] [Abstract][Full Text] [Related]
18. Saposins: structure, function, distribution, and molecular genetics.
Kishimoto Y; Hiraiwa M; O'Brien JS
J Lipid Res; 1992 Sep; 33(9):1255-67. PubMed ID: 1402395
[TBL] [Abstract][Full Text] [Related]
19. Mesotrypsin and caspase-14 participate in prosaposin processing: potential relevance to epidermal permeability barrier formation.
Yamamoto-Tanaka M; Motoyama A; Miyai M; Matsunaga Y; Matsuda J; Tsuboi R; Hibino T
J Biol Chem; 2014 Jul; 289(29):20026-38. PubMed ID: 24872419
[TBL] [Abstract][Full Text] [Related]
20. Distribution of prosaposin in the rat nervous system.
Hosoda Y; Miyawaki K; Saito S; Chen J; Bing X; Terashita T; Kobayashi N; Araki N; Shimokawa T; Hamada F; Sano A; Tanabe H; Matsuda S
Cell Tissue Res; 2007 Nov; 330(2):197-207. PubMed ID: 17763872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
